· Help People Breathe. Vent19 is a 501(c)(3) nonprofit developing rapidly mass producible solutions to help people breathe.
· tVent19 – An emergency use ventilator made from a mechanical 3d-printable part and a bi-level CPAP machine with a backup rate.
· BiVent19 – An emergency use ventilator made from two mechanical 3d-printable parts without any special materials or electronic components and a bi-level CPAP machine (Bi-PAP). The BiVent19 builds on the tVent19 by adding compatibility with bi-level CPAP machines that do not have a backup rate. This makes millions of additional devices capable of working as ventilators and reduces the cost 3 fold as b-level CPAP machines without a backup rate are less than a third of the cost of those with a backup rate and are much more plentiful.
· cVent19 – An emergency use ventilator made from three 3d-printable parts without any special materials or electronic components and a CPAP machine. The cVent19 adds compatibility with CPAP machines making tens of millions of additional devices capable of working as ventilators and further reduces the cost another 3-fold CPAP machines may be purchased for under $200 and Vent19’s parts may be printed for $10 providing an incredibly scalable and incredibly cost effective solution to the ventilator shortage in addition to its benefits opening up non-invasive ventilation as a management strategy.
· Wall Street Journal features Vent19’s founder, Dr. Pankaj Merchia, as it reviews open source ventilator projects to help patients affected by the COVID-19 pandemic.
We at Vent19 have been amazed and are incredibly grateful for the support that we have received from many individuals and organizations including:
· Faculty, alumni, and students at the Harvard Medical School and Massachusetts Institute of Technology Division of Health Sciences and Technology (HST).
· Faculty and students at the Johns Hopkins University Department of Biomedical Engineering, Applied Physics Lab, and Medical School.
· Individuals in industry and at other projects working to find solutions to the respiratory challenges of COVID-19 – an incredible global collaboration.
Vent19 Corp is a 501(c)(3) nonprofit corporation dedicated to the development of readily available and affordable ventilator solutions to help patients affected by coronavirus during the COVID-19 pandemic.
· Dr. Pankaj Merchia founded Vent19 to develop an affordable ventilator that may be rapidly produced for patients affected by the COVID-19 pandemic by using a 3d-printer and generally available CPAP machines. Dr. Merchia is a physician, engineer, and entrepreneur. He clinically trained at Harvard and Duke, earned his MD from Harvard Medical School and Massachusetts Institute of Technology, and got bachelors in Biomedical Engineering, Electrical & Computer Engineering, and Mathematics from Johns Hopkins.
· Dr. Shona Pendse, former FDA senior medical officer. Prior to the FDA, Dr. Pendse served as a physician, scientist, and faculty member at Harvard Medical School. Dr. Pendse received her M.D. from Harvard Medical School and completed her clinical training at Beth Israel Deaconess Medical Center, Brigham & Women’s Hospital, and Massachusetts General Hospital.
· Dr. Anil Pendse, former FDA senior reviewer of chemistry, manufacturing, and controls. Prior to the FDA, Dr. Pendse worked on research and manufacturing in the pharmaceutical, fine chemicals, and polymer chemistry industries. Dr. Pendse has a Ph.D from the University of Bombay.
· We have assembled a team of Mechanical and Biomedical Engineers with decades of research and industry experience to help us develop our products.
Please send inquiries to Dr. Pankaj Merchia at email@example.com .
· The core technologies used in Vent19’s products are Patent Pending.
· Vent19’s 3d-printable emergency ventilator designs are under development and are not presently approved by the FDA. These devices should not be used for patient care until they receive FDA approval. Approved ventilators should only be used under medical supervision. Emergency ventilators should only be used when a standard ventilator is not available and the supervising physician believes it may save a patient’s life. These designs are being developed for and should only be used in the setting of the coronavirus pandemic of 2020, COVID-19. Use of these unapproved ventilator designs may cause death. Use should only be in an emergency when the supervising physician understands the device’s limitations and has advised the patient and their family of its limitations and the risk of death.